BioCentury | Jun 26, 2019
Financial News

Spain’s Sanifit heads to Phase III with €72.2M in new funding

...million ($62.8 million) in series D funding for Laboratoris Sanifit S.L. (Palma, Spain), led by Caixa Capital...
BioCentury | Oct 5, 2018
Financial News

Minoryx raises €21M series B, advances MIN-102

...as did existing investors Ysios Capital, Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi Ventures, Caixa Capital...
BioCentury | May 10, 2018
Emerging Company Profile

Abac’s precision platform

...Health Science Center Corporate partners: None Number of employees: 4 Funds raised: €16 million Investors: Caixa Capital...
BioCentury | Feb 16, 2018
Finance

Quark gets specific

...round, which closed on Feb. 15. Fellow new investors GF Securities Co. Ltd. (SZSE:00076; HKSE:1776), Caixa Capital...
BioCentury | Feb 16, 2018
Financial News

Abac raises €16M series A

...15 in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital...
BioCentury | Feb 15, 2018
Financial News

Pontifax leads Abac’s €16M series A round

...million) in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital...
BioCentury | Apr 18, 2016
Financial News

Stat-Diagnostica and Innovation completes venture financing

...Investors: Gilde Healthcare Partners; Kurma Partners; Ysios Capital Partners; Idinvest Partners; Boehringer Ingelheim Venture Fund; Caixa Capital...
BioCentury | Jan 18, 2016
Financial News

Aelix Therapeutics completes venture financing

...financing Raised: EUR11.5 million ($12.5 million) Investors: Ysios Capital Partners; Johnson & Johnson Development Corp.; Caixa Capital WIR...
BioCentury | Jan 12, 2016
Financial News

Aelix raises EUR 11.5M in series A

...Ysios Capital. The Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ) and Caixa Capital...
...to last through completion of a Phase II trial in 2019. Ysios Capital's Karen Wagner, Caixa Capital's...
BioCentury | Oct 19, 2015
Finance

From Actos to act two

...investors in the series A included Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi Ventures, Caixa Capital...
Items per page:
1 - 10 of 16
BioCentury | Jun 26, 2019
Financial News

Spain’s Sanifit heads to Phase III with €72.2M in new funding

...million ($62.8 million) in series D funding for Laboratoris Sanifit S.L. (Palma, Spain), led by Caixa Capital...
BioCentury | Oct 5, 2018
Financial News

Minoryx raises €21M series B, advances MIN-102

...as did existing investors Ysios Capital, Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi Ventures, Caixa Capital...
BioCentury | May 10, 2018
Emerging Company Profile

Abac’s precision platform

...Health Science Center Corporate partners: None Number of employees: 4 Funds raised: €16 million Investors: Caixa Capital...
BioCentury | Feb 16, 2018
Finance

Quark gets specific

...round, which closed on Feb. 15. Fellow new investors GF Securities Co. Ltd. (SZSE:00076; HKSE:1776), Caixa Capital...
BioCentury | Feb 16, 2018
Financial News

Abac raises €16M series A

...15 in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital...
BioCentury | Feb 15, 2018
Financial News

Pontifax leads Abac’s €16M series A round

...million) in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital...
BioCentury | Apr 18, 2016
Financial News

Stat-Diagnostica and Innovation completes venture financing

...Investors: Gilde Healthcare Partners; Kurma Partners; Ysios Capital Partners; Idinvest Partners; Boehringer Ingelheim Venture Fund; Caixa Capital...
BioCentury | Jan 18, 2016
Financial News

Aelix Therapeutics completes venture financing

...financing Raised: EUR11.5 million ($12.5 million) Investors: Ysios Capital Partners; Johnson & Johnson Development Corp.; Caixa Capital WIR...
BioCentury | Jan 12, 2016
Financial News

Aelix raises EUR 11.5M in series A

...Ysios Capital. The Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ) and Caixa Capital...
...to last through completion of a Phase II trial in 2019. Ysios Capital's Karen Wagner, Caixa Capital's...
BioCentury | Oct 19, 2015
Finance

From Actos to act two

...investors in the series A included Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi Ventures, Caixa Capital...
Items per page:
1 - 10 of 16